A new approach to raising efficiency of pharmacotherapy of erectile dysfunction

Terapevticheskii Arkhiv

Volumn 74, Issue 10, 2002, Pages 75-77

  Dmitriev, D G ^a   Gamidov, S I ^a   Mazo, E B ^a   Ovchinnikov, R I ^a  

^a NONE

Author keywords

Alprostadil; Combined chemotherapy; Erectile dysfunction; Treatment; Viagra

Indexed keywords

PIPERAZINE DERIVATIVE; PROSTAGLANDIN E1; SILDENAFIL;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; HUMAN; IMPOTENCE; MALE; MIDDLE AGED;

ADULT; AGED; ALPROSTADIL; HUMANS; IMPOTENCE; MALE; MIDDLE AGED; PIPERAZINES;

EID: 0036047145     PISSN: 00403660     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Feldman H. S., Goldstein I., Hatzichristou D. G. et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study J. Urol. (Baltimore) 1994; 151: 54-61.
2. Lue T. F. Erectile dysfunction: problems and challenges. Ibid. 1993; 149: 1256-1257.
3. Derry F. A., Dinsmore W. W., Frawer M. et al. Efficacy and safety of oral sildenafil (Viagra) in men erectile dysfunction caused by spinal cord injury. Neurology 1998; 51: 1629-1633.
4. Hatzichristou D. Current treatment and future perspective for erectile dysfunction. Int. J. Impot. Res. 1998; 10: 3-13.
5. Iribarren I. M., Saenz de Tejada Y Pharmacologycal treatment of erectile dysfunction. Curr. Opin. Urol. 1999; 9: 547-551.
6. Goldstein I., Lue T. F., Padms-Nathan H et al. Oral sildenafil in the treatment of erectile dysfunction. N. Engl. J. Med. 1998: 338: 1397-1404.
7. Wespws E., Amar E., Hatzichristou D. et al. Guidelines of erectile dysfunction. Eur. Urol. 2002; 41: 1-5
8. Buvat J., Gingell C. J., Jardin A et al. Sildenafil (Viagra), an oral treatment for erectile dysfunction: a 1-year, open-label, extension study. J. Urol. (Baltimore) 1997; 157 (suppl. 4): 204, abstr, 193.
9. Morales A., Gingell C., Collins M. et al. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int. J. Impot. Res. 1998: 10: 69-73.
10. Schmid D. M., Schurch B., Hauri D. Silfenafil in the treatment of sexual dysfunction in spinal cord - injure male patients Eur. Urol. 2000; 38: 184-193.
11. El-Galley R., Rutland H., Talic R et al Long-term efficacy of sildenafil and tachyphylaxis effect. J. Urol (Baltimore) 2001; 66: 927-931.
12. Rosen R. C., Riley A., Wagner G. et al. The International Index of Erectile Function (IIEF): multidimentional scale for assessment of erectile dysfunction. Urology 1997; 49: 822-830/
13. Altof S., Corty F., Levine S. et al. EDITS: development of questionnaires for evaluating with treatments for erectile dysfunction. Ibid. 1999; 53: 793-399.
14. Porst H., Buvat J., Meuleman E. et al. Intracavernosus alprostadil alfadex: an effective and well tolerated treatment for erectile dysfunction. Results of a long therm European study. Int. J. Import. Res. 1998, 10: 225-231.